Ropes & Gray advised MOMA Therapeutics on the transaction. MOMA Therapeutics announced it has entered into a collaboration and exclusive license agreement with Bayer to develop...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised MOMA Therapeutics on the deal. MOMA Therapeutics announced a collaboration and licensing agreement with Swiss pharmaceutical leader Roche (SIX: RO, ROG; OTCQX: RHHBY)....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised MOMA Therapeutics on the deal. MOMA Therapeutics announced its completion of a $150 million Series B Financing. MOMA Therapeutics is a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
